Anne Cayre

4.6k citations

81 papers · 3.1k indexed · 2 hit papers · h-index 26

Impact in

Oncology top 1%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Cancer Research top 2%
- Cancer Genomics and Diagnostics

Papers in

Cancer Research 28
- Breast Cancer Treatment Studies 13
- Cancer Genomics and Diagnostics 8
Oncology 49
- HER2/EGFR in Cancer Research 13
- Colorectal Cancer Treatments and Studies 13
- Cancer Treatment and Pharmacology 11

Co-authors: Frédérique Penault‐Llorca Pierre Laurent‐Puig Jean‐Baptiste Bachet Frédéric Bibeau Philippe Rougier Michel Ducreux Emmanuel Buc Astrid Lièvre
Journals: Journal of Clinical Oncology (9 papers)Clinical Cancer Research (3 papers)Annals of Oncology (3 papers)International Journal of Oncology (3 papers)Oncotarget (3 papers)
Partner nations: France United States Belgium

In The Last Decade

Anne Cayre

76 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer 2009 · 529 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Journal of Clinical Oncology
2008 Journal of Clinical Oncology

Peers

Countries citing papers authored by Anne Cayre

Since Specialization

Citations

This map shows the geographic impact of Anne Cayre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Cayre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Cayre more than expected).

Fields of papers citing papers by Anne Cayre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Cayre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Cayre. The network helps show where Anne Cayre may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Cayre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Cayre Line = papers co-authored together Anne Cayre links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLC Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Linea Melchior, Astrid Hirschmann, Paul Hofman, Christophe Bontoux, Ángel Concha, Salima Mrabet-Dahbi, Pascal Vannuffel, Emmanuel Watkin, Martina Putzová, Stefania Scarpino, Anne Cayre, Paloma Martín, Robert Stoehr, Arndt Hartmann	2024	1
2	444P Prevalence of NTRK1/2/3 fusions in dMMR/MSI metastatic colorectal cancer Annals of Oncology ·Magali Svrcek, Raphaël Colle, Anne Cayre, Léo Mas, Pierre Bourgoin, Romain Cohen, Thierry André, Frédérique Penault‐Llorca, Nina Radosevic‐Robin	2021	1
3	Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies European Journal of Cancer ·Florence Koeppel, Etienne Müller, Alexandre Harlé, C Guien, Pierre Sujobert, Olfa Trabelsi Grati, Olivier Kosmider, Laurent Miguet, Laurent Mauvieux, Anne Cayre, David Salgado, Claude Preudhomme, Lucie Karayan‐Tapon, Gaëlle Tachon, Florence Coulet, Alexandra Lespagnol, Christophe Béroud, Karen Leroy, Etienne Rouleau, Isabelle Soubeyran	2021	10
4	Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer PLoS ONE ·Abderrahim El Guerrab, Anne Cayre, Fabrice Kwiatkowski, Maud Privat, Jean-Marc Rossignol, Fabrice Rossignol, Frédérique Penault‐Llorca, Yves‐Jean Bignon	2017	13
5	Stratégie de testing moléculaire des carcinomes pulmonaires Annales de Pathologie ·Frédérique Penault‐Llorca, L. Tixier, L. Perrot, Anne Cayre	2016	4
6	[123I]ICF01012 melanoma imaging and [131I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models European Journal of Dermatology ·Claire Viallard, Y. Perrot, Zied Boudhraa, E. Jouberton, Elisabeth Miot-Noirault, Mathilde Bonnet, Sophie Besse, Florence Mishellany, Anne Cayre, Lydia Maigne, Latifa Rbah‐Vidal, M. D’Incan, F. Cachin, Jean‐Michel Chezal, Françoise Degoul	2015	16
7	Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions Clinical Cancer Research ·Geneviève Chêne, Andréï Tchirkov, Eléonore Pierre-Eymard, J Dauplat, Inès Raoelfils, Anne Cayre, Emmanuel Watkin, Philippe Vago, Frédérique Penault‐Llorca	2013	31
8	Instant‐quality fluorescence in‐situ hybridization as a new tool for HER2 testing in breast cancer: a comparative study Histopathology ·Camille Franchet, Thomas Filleron, Anne Cayre, Eveline Mounié, Frédérique Penault‐Llorca, Jocelyne Jacquemier, Gaëtan MacGrogan, Laurent Arnould, Magali Lacroix‐Triki	2013	9
9	Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02) Clinical Cancer Research ·Juliette Thariat, René‐Jean Bensadoun, Marie-Christine Étienne-Grimaldi, Dominique Grall, Frédérique Penault‐Llorca, O. Dassonville, François Bertucci, Anne Cayre, D. De Raucourt, Lionnel Geoffrois, Pascal Finetti, P. Giraud, S. Racadot, S. Morinière, Anne Sudaka, Ellen Van Obberghen‐Schilling, G. Milano	2012	26
10	N’oubliez pas les trompes ! Étude morphologique et immunohistochimique des trompes à risque génétique (mutation BRCA) Gynécologie Obstétrique & Fertilité ·Geneviève Chêne, Inès Raoelfils, Anne Cayre, J Dauplat, Yves‐Jean Bignon, P. Jaffeux, Bruno Aublet‐Cuvelier, Frédérique Penault‐Llorca	2011	8
11	Melanoma vectorized radiotherapy: preclinical evaluation of a new marker labelled by iodine 131 Médecine Nucléaire ·Mathilde Bonnet, Janine Papon, Elisabeth Miot‐Noirault, J. C. Madelmont, Jean‐Michel Chezal, Nicole Moins, Florence Mishellany, F. Penault-Llorca, Anne Cayre	2010	1
12	Analysis of PTEN , BRAF , and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer Journal of Clinical Oncology ·Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau, Emmanuel Buc, Jean‐Baptiste Bachet, Thierry Lecomte, Philippe Rougier, Astrid Lièvre, Bruno Landi, Valérie Boige, Michel Ducreux, Marc Ychou, Frédéric Bibeau, Olivier Bouché, Julia Reid, Steven Stone, Frédérique Penault‐Llorca Hit paper breakdown →	2009	529
13	KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab Journal of Clinical Oncology ·Astrid Lièvre, Jean‐Baptiste Bachet, Valérie Boige, Anne Cayre, Delphine Le Corre, Emmanuel Buc, Marc Ychou, Olivier Bouché, Bruno Landi, Christophe Louvet, Thierry André, Frédéric Bibeau, Marie-Danièle Diébold, Philippe Rougier, Michel Ducreux, Gorana Tomasic, Jean‐François Emile, Frédérique Penault–Llorca, Pierre Laurent‐Puig Hit paper breakdown →	2008	1141
14	Comparison of the prognostic significance of Chevallier and Sataloff's pathologic classifications after neoadjuvant chemotherapy of operable breast cancer Human Pathology ·Frédérique Penault‐Llorca, Catherine Abrial, Inès Raoelfils, Anne Cayre, Marie‐Ange Mouret‐Reynier, Marianne Leheurteur, Xavier Durando, J.L. Achard, Pierre Gimbergues, P. Chollet	2008	51
15	Vincristine-Induced Neuropathy in the Rat Is Not Modified by Drug-Drug Interactions with the P-Glycoprotein Inhibitor Verapamil Chemotherapy ·David Balayssac, Anne Cayre, Bing Ling, J. Maublant, Frédérique Penault‐Llorca, Alain Eschalier, François Coudoré, Nicolas Authier	2008	5
16	[Assessment of HER2 status in breast cancer]. PubMed ·Frédérique Penault‐Llorca, Anne Cayre	2004	3
17	Actualité des tests HER2 dans le cancer du sein Bulletin du Cancer ·Frédérique Penault‐Llorca, Anne Cayre	2004	2
18	Natural antisense transcripts of HIF-1α are conserved in rodents Gene ·Fabrice Rossignol, Elodie de Laplanche, Rémi Mounier, Jérôme Bonnefont, Anne Cayre, Catherine Godinot, Hélène Simonnet, Eric Clottes	2004	32
19	Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome International Journal of Oncology ·Frédérique Penault‐Llorca, Anne Cayre, Florence Mishellany, S. Amat, V. Feillel, G. Le Bouëdec, Jean-Pierre Ferrière, M de Latour, P. Chollet	2003	64
20	aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer Breast Cancer Research ·Anne Cayre, Fabrice Rossignol, Eric Clottes, Frédérique Penault‐Llorca	2003	80

About Anne Cayre

Anne Cayre is a scholar working on Cancer Research, Oncology, Reproductive Medicine, Pathology and Forensic Medicine and Otorhinolaryngology, having authored 81 papers that have together received 3.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (13 papers), Colorectal Cancer Treatments and Studies (13 papers), Breast Cancer Treatment Studies (13 papers), Lung Cancer Treatments and Mutations (12 papers), Cancer Treatment and Pharmacology (11 papers), Genetic factors in colorectal cancer (9 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer Genomics and Diagnostics (8 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (822 citations), Pathology and Forensic Medicine (829 citations), Hepatology (295 citations) and Pulmonary and Respiratory Medicine (840 citations). Anne Cayre has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Frédérique Penault‐Llorca, Pierre Laurent‐Puig, Jean‐Baptiste Bachet, Frédéric Bibeau, Philippe Rougier, Michel Ducreux, Emmanuel Buc, Astrid Lièvre, Bruno Landi and Valérie Boige. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, International Journal of Oncology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact